Allergic respiratory disease care in the COVID-19 era: A EUFOREA statement

Glenis K. Scadding; Peter W. Hellings; Claus Bachert; Leif Bjermer; Zuzana Diamant; Philippe Gevaert; Anette Kjeldsen; Jorge Kleine-Tebbe; Ludger Klimek; Antonella Muraro; Graham Roberts; Andreas Steinsvik; Martin Wagenmann; Ulrich Wahn

doi:10.1016/j.waojou.2020.100124

Allergic respiratory disease care in the COVID-19 era: A EUFOREA statement

Glenis K. Scadding, Peter W. Hellings, Claus Bachert, Leif Bjermer, Zuzana Diamant, Philippe Gevaert, Anette Kjeldsen, Jorge Kleine-Tebbe, Ludger Klimek, Antonella Muraro, Graham Roberts, Andreas Steinsvik, Martin Wagenmann, Ulrich Wahn

Forskningsoutput: Tidskriftsbidrag › Letter

Sammanfattning

Spring and Summer 2020 are unique in that the challenges of care for those suffering from pollen allergy coincide with the COVID-19 pandemic. Several considerations are important to allow optimal care of allergic rhinitis (AR) and asthma and hence prevention of coronavirus spread through sneezing, rhinorrhoea, and coughing. This compact overview of recommendations by the EUFOREA expert teams on allergic airway diseases and allergen-specific immunotherapy (AIT) is based on investigation of the current COVID-19 literature in association with the key words above and shared clinical experience of the experts involved. It deals with similarities and differences between AR and coronavirus infection, specific recommendations for allergic disease care in the COVID-19 era, including guidance on AIT.

Originalspråk	engelska
Artikelnummer	100124
Tidskrift	World Allergy Organization Journal
Volym	13
Nummer	5
DOI	https://doi.org/10.1016/j.waojou.2020.100124
Status	Published - 2020 maj 16

Ämnesklassifikation (UKÄ)

Lungmedicin och allergi

Tillgång till dokument

10.1016/j.waojou.2020.100124Licens: CC BY-NC-ND

Andra filer och länkar

Link to publication in Scopus

Citera det här

Scadding, G. K., Hellings, P. W., Bachert, C., Bjermer, L., Diamant, Z., Gevaert, P., Kjeldsen, A., Kleine-Tebbe, J., Klimek, L., Muraro, A., Roberts, G., Steinsvik, A., Wagenmann, M., & Wahn, U. (2020). Allergic respiratory disease care in the COVID-19 era: A EUFOREA statement. World Allergy Organization Journal, 13(5), Artikel 100124. https://doi.org/10.1016/j.waojou.2020.100124

@article{2e7a81d4b3d3445894237a9afd24166e,

title = "Allergic respiratory disease care in the COVID-19 era: A EUFOREA statement",

abstract = "Spring and Summer 2020 are unique in that the challenges of care for those suffering from pollen allergy coincide with the COVID-19 pandemic. Several considerations are important to allow optimal care of allergic rhinitis (AR) and asthma and hence prevention of coronavirus spread through sneezing, rhinorrhoea, and coughing. This compact overview of recommendations by the EUFOREA expert teams on allergic airway diseases and allergen-specific immunotherapy (AIT) is based on investigation of the current COVID-19 literature in association with the key words above and shared clinical experience of the experts involved. It deals with similarities and differences between AR and coronavirus infection, specific recommendations for allergic disease care in the COVID-19 era, including guidance on AIT.",

keywords = "Allergen-specific immunotherapy, Allergy, Asthma, Control, COVID-19, Rhinitis, Smell and taste, Symptoms, Treatment",

author = "Scadding, {Glenis K.} and Hellings, {Peter W.} and Claus Bachert and Leif Bjermer and Zuzana Diamant and Philippe Gevaert and Anette Kjeldsen and Jorge Kleine-Tebbe and Ludger Klimek and Antonella Muraro and Graham Roberts and Andreas Steinsvik and Martin Wagenmann and Ulrich Wahn",

year = "2020",

month = may,

day = "16",

doi = "10.1016/j.waojou.2020.100124",

language = "English",

volume = "13",

journal = "World Allergy Organization Journal",

issn = "1939-4551",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - Allergic respiratory disease care in the COVID-19 era

T2 - A EUFOREA statement

AU - Scadding, Glenis K.

AU - Hellings, Peter W.

AU - Bachert, Claus

AU - Bjermer, Leif

AU - Diamant, Zuzana

AU - Gevaert, Philippe

AU - Kjeldsen, Anette

AU - Kleine-Tebbe, Jorge

AU - Klimek, Ludger

AU - Muraro, Antonella

AU - Roberts, Graham

AU - Steinsvik, Andreas

AU - Wagenmann, Martin

AU - Wahn, Ulrich

PY - 2020/5/16

Y1 - 2020/5/16

N2 - Spring and Summer 2020 are unique in that the challenges of care for those suffering from pollen allergy coincide with the COVID-19 pandemic. Several considerations are important to allow optimal care of allergic rhinitis (AR) and asthma and hence prevention of coronavirus spread through sneezing, rhinorrhoea, and coughing. This compact overview of recommendations by the EUFOREA expert teams on allergic airway diseases and allergen-specific immunotherapy (AIT) is based on investigation of the current COVID-19 literature in association with the key words above and shared clinical experience of the experts involved. It deals with similarities and differences between AR and coronavirus infection, specific recommendations for allergic disease care in the COVID-19 era, including guidance on AIT.

AB - Spring and Summer 2020 are unique in that the challenges of care for those suffering from pollen allergy coincide with the COVID-19 pandemic. Several considerations are important to allow optimal care of allergic rhinitis (AR) and asthma and hence prevention of coronavirus spread through sneezing, rhinorrhoea, and coughing. This compact overview of recommendations by the EUFOREA expert teams on allergic airway diseases and allergen-specific immunotherapy (AIT) is based on investigation of the current COVID-19 literature in association with the key words above and shared clinical experience of the experts involved. It deals with similarities and differences between AR and coronavirus infection, specific recommendations for allergic disease care in the COVID-19 era, including guidance on AIT.

KW - Allergen-specific immunotherapy

KW - Allergy

KW - Asthma

KW - Control

KW - COVID-19

KW - Rhinitis

KW - Smell and taste

KW - Symptoms

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=85085645917&partnerID=8YFLogxK

U2 - 10.1016/j.waojou.2020.100124

DO - 10.1016/j.waojou.2020.100124

M3 - Letter

C2 - 32426089

AN - SCOPUS:85085645917

SN - 1939-4551

VL - 13

JO - World Allergy Organization Journal

JF - World Allergy Organization Journal

IS - 5

M1 - 100124

ER -

Allergic respiratory disease care in the COVID-19 era: A EUFOREA statement

Sammanfattning

Ämnesklassifikation (UKÄ)

Tillgång till dokument

Andra filer och länkar

Fingeravtryck

Citera det här